Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Alii Supplement

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07271316Phase 2Completed

Alii Supplement Study

NCT01426022Not ApplicableCompletedPrimary

Effect of Moderate Alcohol Consumption on Postprandial Mood

Showing all 2 trials

Research Network

Common Treatments

  • Alii Supplement1
  • Mood Manipulation1
  • Nutrition1

Active Sponsors

  • TNO1
  • Texas Christian University1

Top Investigators

Related Conditions

  • Vulnerability To Disease1
  • Happiness1
  • Digestive Health1
  • Energy1
  • Nutrient Deficiency1

Activity Timeline